Dr. Thomas Giordano, M.D., Ph.D, the Henry Clay Bryant Professor of Pathology, led an international study on the genomics of adrenal cancer. The project was one of the 33 projects that comprise The Cancer Genome Atlas (TCGA) project of the NCI and NHGRI. The study results were published in Cancer Cell.
We invite you to be a part of the Clinical Pathology Symposium. We hope that you find the symposium a rewarding and educational experience that you can share with your colleagues.
Congratulations to Kristina Davis, M.D. who was selected by the Abstracts Committee of the American Society for Apheresis as the recipient of the 2016 Junior Investigator Award.
Dr. Ulysses Balis, M.D., Director of Pathology Informatics, was recently quoted in CAP Todays' Newsbytes. In the April 2016 news post, Dr. Balis advises on finding, fixing, and foiling shadow IT problems based on his experience here at UMHS.
View the full article online at:
The laboratory of Dr. Yali Dou, Ph.D., Associate Professor of Pathology, reported new findings in the article “PRDM16 suppresses MLL1r leukemia via intrinsic histone methyltransferase activity” which was published in the journal Molecular Cell on April 27th, 2016. Dr. Bo Zhou is the first author. Other co-authors from the Department include Shirley Y. Lee, Yuqing Sun, and Rajesh C. Rao. The article can be found online at:
The 2016 Cancer Metabolism Symposium will be held on Wednesday, May 25 at 9:00 a.m.-4:30 p.m. in Kahn Auditorium, Biomedical Science Research Building.
This event is organized by David Lombard and Sriram Venneti. Admission is free and advance registration is preferred. Please visit www.surveymonkey.com/r/CellMetabolism2016 to register.
Abstract submission deadline is May 4, 2016. Registration deadline is May 23, 2016.
Dr. Thomas Giordano is a co-author on an international study on the reclassification of a particular type of thyroid tumor which was published in the journal JAMA Oncology. This study has the potential to reduce over diagnosis and overtreatment of some patients with a particular type of thyroid cancer.
The story was highlighted in the NYTimes: http://www.nytimes.com/2016/04/15/health/thyroid-tumor-cancer-reclassification.html?smid=tw-nythealth&smtyp=cur
The story can also be found here: http://labblog.uofmhealth.org/lab-report/when-its-not-exactly-cancer-renaming-early-stage-thyroid-tumors